TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/9/23 16:38 | 1/6/23 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilson Kevin S. | CO | DO | CEO,P | P | 646 | 58.62 | 0 | 11 | 2 | 478 | D | ||||||||||||||
12/27/22 12:45 | 12/22/22 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilson Kevin S. | CO | DO | CEO,P | P | 205 | 59.64 | 0 | 3 | 1 | 467 | D | ||||||||||||||
2/14/22 16:43 | 2/11/22 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilson Kevin S. | CO | DO | CEO,P | M.d | 914 | 20.25 | 0 | 45 | 11 | 443 | D | ||||||||||||||
11/23/21 16:29 | 11/23/21 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilson Kevin S. | CO | DO | CEO,P | P | 173 | 173.00 | 0 | 1 | 0 | 398 | I | ||||||||||||||
11/15/21 17:42 | 11/15/21 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilson Kevin S. | CO | DO | CEO,P | P | 179 | 179.00 | 0 | 1 | 0 | 397 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |